key: cord-0874427-8l03slm7
authors: Zhu, Liting; Liu, Shiguo; Zhuo, Zewen; Lin, Yanxi; Zhang, Yanni; Wang, Xiaoling; Kong, Lingbao; Wang, Ting
title: Expression and immunogenicity of nsp10 protein of porcine epidemic diarrhea virus
date: 2022-01-03
journal: Res Vet Sci
DOI: 10.1016/j.rvsc.2021.12.024
sha: 687638c369e38bfda495635f107f7fa6a49d3a95
doc_id: 874427
cord_uid: 8l03slm7

Porcine epidemic diarrhea virus (PEDV), a swine enteropathogenic coronavirus, causes lethal watery diarrhea to the piglets, which poses significant economic losses and public health concerns. The nsp10 protein of PEDV is essential regulatory subunits that are critical for virus replication. Since PEDV nsp10 is a crucial regulator of viral RNA synthesis, it is promising that nsp10 might become anti-virus drugs target or candidate for rapid diagnosis of PEDV infection. In this study, the PEDV nsp10 was inserted into pMAL-c2x-MBP / pET-28a vector, efficiently and stably expressed in E.coli system. Then the purified nsp10 protein was found to mediate potent antibody responses in immunized mice. The antibodies of immunized mice and PEDV infection swine strongly recognized purified nsp10 protein from cell lysates. Furthermore, cytokines test revealed that the expression of IL-2, IL-4, IL-10, TNF-α, IFN-γ were significantly higher than those in control group, indicated that purified nsp10 protein induce the cellular immune response mechanism in mice. Using modified seroneutralization test, we also demonstrated that sera from nsp10-immunized mice inhibited PEDV replication to some extent. These findings suggest that nsp10 has a high immunogenicity. This study may have implications for future development of PEDV detection or anti-virus drugs for swine.

which include ORF1a, ORF1b, S, ORF3, E, M and N genes (Duarte et al., 1993; Song and Park, 2012) . The ORF1a and ORF1b encode two large replicase polyprotein (pp1a and pp1ab), which are subsequently processed into 16 nonstructural proteins (nsp1 to 16) (Subissi et al., 2014) .

Nsp10 protein is existent exclusively in CoVs so far which is a zinc-finger protein through detecting the crystal structure of SARS CoV nsp10 protein (Joseph et al., 2006) . Crystallographic or nuclear magnetic resonance structures have shown that nsp10 have the ADP-ribose 1-phosphatase (ADRP) activity and RNA binding activity (Anand et al., 2002) . Nsp10 is a crucial regulator involved in viral RNA synthesis and is necessary for viral replication via regulating the nsp14 ExoN and nsp16 2'-O-MTase activities (Bouvet et al., 2010; Bouvet et al., 2012; Donaldson et al., 2007b) . The nsp16 S-methyltransferase activity can only be activated when combined with nsp10 as dimer structure (Decroly et al., 2011) . In addition, nsp10 also forms a complex with nsp14 to promote the cleavage effect of mismatched nucleotides by nsp14 (Bouvet et al., 2012) .

Donaldson et al reported that mutant variant of nsp10 inhibits the main protease, 3CLpro, blocking its function completely at the nonpermissive temperature which implicate nsp10 as being a critical factor in the activation of 3CLpro function (Donaldson et al., 2007a) . Furthermore, PEDV nsp10 enhances the inhibitory effect of nsp16 on IFN-β production, negatively regulates innate immunity to promote viral proliferation (Shi et al., 2019) . Considering these biological features of the nsp10 protein, it would be an appropriate target for developing effective detection tool or drugs against PEDV.

In the study, nsp10 protein were constitutively expressed in Escherichia coli (BL21) and explored for its ability to induce immune responses. We found that nsp10 was capable of inducing an efficient antibody response in immunized mice and high expression of cytokines in lymphocytes of mouse spleen.

could be the antisera from mice immunized with the nsp10 protein, antisera from healthy or PEDV-infected swine; commercial antibodies against His-tag, or MBP-tag. The membranes were then incubated with HRP-conjugated secondary antibodies: goat anti-mouse or -swine. Finally, the proteins were visualized with Clarity ECL Immunoblotting substrate (Bio-Rad).

Kunming mice were randomly assigned to the following groups and immunized with 50 μg of the recombinant proteins in the presence of complete Freud's adjuvant (subcutaneous). The mice were subsequently boosted by the same method twice at one-week intervals with incomplete followed by the blocked with 5% non-fat milk for one hour at room temperature. After extensive wash with PBST, mouse serum samples were added to wells and incubated at 37°C for 1 hour.

After extensive wash, HRP-conjugated goat anti-mouse antibody was added to the wells for one hour-incubation at room temperature. Finally, substrates were added to the plate. The absorbance of each well was measured with a Bio-Rad microplate reader at a wavelength of 450 nm.

2.9 Cytokine profiling in serum and splenocytes Sera and splenocytes were collected from protein-immunized mice. Cytokines including IL-4, TNF-α in serum samples and supernatant from cells treated with purified nsp10 protein were measured by ELISA as described previously. Briefly, the harvested sera were added to the pre-coated ELISA plate. After incubation for one hour at room temperature, 50 μl of biotinylated antibody was added to each well and incubated for 90 min at 37℃. After 4 times of wash, 100 μl of streptavidin-HRP was added to each well. The plates were sealed and incubated at 37℃ for 30 min. After adding substrate for development, the absorbance was recorded at 450 nm. The mRNA expression of Cytokines including IL-2, IL-4, IL-10, TNF-α, IFN-γ in splenocytes were detected by Real-time PCR as described previously (Matsuda, 2017) . In brief, Gene expressions were quantified using TB Green®Premix Ex Taq™II (Takara Biotechnology, China) and the qRT-PCR was performed in an Applied Biosystems® 7500 Fast Real-time System. The primers were J o u r n a l P r e -p r o o f Journal Pre-proof specific designed using Primer Premier 5.0 (Table 1) . The seroneutralization experiment was proceeded as previously described with minor modifications (Gauger and Vincent, 2014; Li et al., 2020) . Vero cells were seeded with 5 X 10 4 cells per well into 96-well plates at least 6 h prior to infection. The test samples were serially diluted 2-fold from 1:2 to 1:256 with DMEM, four wells were used for each dilution. Then the serial dilution of sera samples were applied to cells and incubated for 1 h at 37℃. After that, the sera samples were removed and cells incubated with 200 TCID 50 of PEDV at 37℃ for 1h. The cytopathic effect was examined for 2 days post-infection. The wells infection with 200 TCID 50 , 20 TCID 50 , 2 TCID 50 of PEDV were considered as virus-infection control.

For standardization of the absolute quantification assay, the cDNA of PEDV N gene was inserted into pCAGGA-HA vector and the plasmid DNA isolated from positive clone DH5α.

qRT-PCR was carried out in a 20-μl reaction mixture with 2 μl cDNA or standard plasmid, 10 μl 2

x SYBR qPCR Master mix, 0.2 μM forward and reverse primers. Amplification and detection were performed in Applied Biosystems® 7500 Fast Real-time System. The specific primers of PEDV N are listed in Table 1 .

Data analysis was performed using GraphPad Prism 8.0 software to determine statistical significance. Statistical differences between two groups were tested with Student's t-test. For all J o u r n a l P r e -p r o o f Journal Pre-proof the tests, P <0.05 was regarded as the statistical significance.

Schematic diagram of the genome of PEDV is shown in Fig. 1A . PEDV nsp10 protein sequence was subjected to Bepipred and Swiss-Model to forecast its linear B cell epitopes and 3D structure, respectively. Using a threshold value 0.5 for Bepipred, 5 potential B cell epitopes were found (Fig. 1B) . It is speculated that main B cell antigen epitope of nsp10 may appear in the 25 to 31, 40 to 63, 77 to 82, 94 to 97, 120 to 124 amino acid residues (Fig. 1C) . B cell antigen epitopes are shown in the Swiss-modeled nsp10 protein structure (Fig. 1D ). Altogether, these results indicate that PEDV nsp10 protein may harbor potential for inducing host immune responses. The fragment of 408 bp was identified by 1.5% agarose gel electrophoresis, which was consistent with the expected size ( Fig. 2A) . After PEDV nsp10 gene was ligated with prokaryotic expression vector pET28a, pMAL-c2x-MBP by double digestion of BamH I, EcoR I, Xho I, Hind III, the ligation product was transformed into E. coli competent cell DH5α. A number of positive clones were randomly selected for PCR identification, and the amplified fragment was 408 bp (Fig. 2B ).

The correct clone strains identified by PCR were selected for plasmid extraction ( Fig. 2C and 2E ).

The recombinant plasmid pMAL-c2x-MBP-nsp10 was identified by double enzyme digestion (Fig.   2D ). Then the recombinant plasmid pET28a-nsp10 was identified by PCR using nsp10 specific primer and T7 primer respectively (Fig. 2F ). The positive clone was sent to Sangon for sequencing.

The sequence of PEDV nsp10 was identified based on a multiple alignment of PEDV CV777 strain. The sequence of positive clone was confirmed through DNAMAN sequence comparison.

The recombinant expression vector pMAL-c2x-MBP-nsp10, pET28a-nsp10 was successfully constructed. The MBP protein in vector pMAL-c2x-MBP was successfully expressed, and the relative molecular weight of the MBP-nsp10 and nsp10 protein was 56kD and 16kD respectively. To obtain the optimal condition of protein expression, we tested different induction temperature ( In addition, we tested the antibody titers of MBP protein and found that the highest titer was at the third week, 1:31000. At the same time, we harvested sera from protein-immunized mice to examine the immunogenicity of these proteins. Immunoblotting results showed that mice sera specifically detected the corresponding recombinant proteins expressed in IPTG-induced transformed E.coli, but not in the un-induced samples (Fig. 4C) . As a negative control, sera from mice treated with PBS did not recognize any recombinant proteins. We further evaluated the nsp10-specific immunogenicity with the sera from PEDV-infected pigs. The data from immunoblotting revealed that nsp10 recognized PEDV-positive pig sera but not PEDV-free pig sera (Fig. 4C right) . Moreover, 30 sera samples from healthy or PEDV-infected pigs were collected, then investigated blindly by using commercial ELISA kit or nsp10 protein. The results

showed that there is a high degree of consistency between PEDV ELISA kit and nsp10-ELISA ( Fig. 4D ). In summary, these data showed that the recombinant nsp10 protein expressed in E.coli retains the antigenicity that sera from PEDV-infected pigs can recognize.

J o u r n a l P r e -p r o o f The results showed that the treatment of nsp10 protein, but not PBS, triggered mice to secrete cytokines substantially (Fig. 5A) . After splenocytes were harvest from mice immunized with nsp10 protein and stimulated by purified nsp10 protein of different concentration in vitro, levels of Th1 (TNF-α) from cell supernatant were examined by ELISA after different incubation time. As shown in Fig. 5B , nsp10 protein triggered more secretions of cytokine TNF-α, compared with PBS treatment group. To further evaluate the cellular immunity at mRNA expression level, expression of cytokine IL-2, IL-4, IL-10, TNF-α, IFN-γ in splenocytes from immunized mice were detected by Real-time PCR assay. The relative expression levels of all genes were calculated by the 2 -△△ Ct algorithm. The internal reference was GAPDH, which is a housekeeping gene.

Compared with PBS immunized group, the expression level of cytokine in the nsp10-immunized group was significantly increased (Fig. 5C ). All the results above collectively demonstrate that nsp10 is capable of initiating cellular immunity.

J o u r n a l P r e -p r o o f of PEDV. We observed the cytopathogenic effect for 2 days and the partial absence of CPE in ＞ 50% of the wells was defined as protection. As shown in Fig. 6A , 2 3 dilution of serum can block CPE in 50% of eight repetitions wells. The findings suggested that nsp10 antibodies may protect cells from PEDV infection. To further detect the absolute quantity of the viral load in serum-treated cells, the N gene expression of PEDV was detected by qRT-PCR as the plasmid pCAGGS-HA-N was used for the generation of a standard curve (Fig. 6B) . The result showed that the copy numbers of PEDV RNA from nsp10 antibodies serum-treated cells were decreased compared with the PEDV-infection cells (Fig. 6C) . The results presented here suggested that nsp10 antibodies from mice sera may inhibit PEDV replication to some extent. 

The coronavirus nsp10 contains two zinc-finger motifs (Matthes et al., 2006) and may function as part of a larger RNA-binding complex (Su et al., 2006) . Previous researches have shown that coronavirus nsp10 is a critical multifunctional factor for activation of multiple replicative enzymes. Nsp10 molecules may thus serve as a platform for the recruitment of nsp14 or nsp16 to the replication-transcription complex in order to either stimulate nsp14 ExoN activity or activate nsp16 2-O-MTase activity (Snijder et al., 2016) . Both nsp10-nsp14 and nsp10-nsp16 complexes may coexist which play essential role in different steps of viral RNA synthesis as part of larger nsp assembling factory (Bouvet et al., 2014) . Considering its importance for virus replication, nsp10 represents an attractive target for anti-coronavirus drug development (Lin et al., 2020; Wang et al., 2015) . Specific molecules or antibodies targeting the nsp10 and inhibiting the interaction with nsp14 and nsp16 might be applied to reduce or prevent virus proliferation (Ke et al., 2012) . Because the nsp10 subunit is among the more conserved coronavirus proteins, such compounds or antibodies could be used in a prophylactic approach to prevent coronavirus infection just like the role of vaccine. The current focus of PEDV nsp10 research is on the interaction of nsp10 with nsp14 and nsp16 to regulate innate immunity Shi et al., 2019) . In the present study, the first aim was to stably express the full-length nsp10 protein of PEDV in E.coli system. Subsequently, we were able to successfully generate a stable E.coli system producing large amounts of nsp10 protein through optimization of expression conditions ( Fig.3A-C) . Following the purification and concentration processes, nsp10 protein could be consistently harvested. Then mice were immunized with nsp10 protein and we determined whether or not they developed humoral immunity. Nsp10-specific antibodies were strongly detectable in mice sera collected from 4 weeks post-inoculation ( Fig. 4A-B) . PEDV-infected pig serum can recognize the E.coli-expressed nsp10 protein, indicating that it has good immunogenicity ( Fig 4C) . Compared with commercial PEDV ELISA kit, nsp10-ELISA had high degree of consistency to detect sera samples of PEDV-infected or uninfected pig (Fig.4D) . It is suggested that PEDV nsp10 may serve as the candidate for developing PEDV detection kit.

PEDV is the main causative pathogen of viral diarrhea in piglets which could cause rapid destruction and detachment of the intestinal physical structure (Wang et al., 2018) . Over the years, a number of works has been done to investigate PEDV pathogenesis and prevention. Vaccination against PEDV is an important measure to prevent and control the rate of PEDV infection (Chen et al., 2017) . However, due to the continued mutation of PEDV genome (Lin et al., 2016) , the current available vaccines cannot provide complete protection for pigs. Therefore, it is important that accumulating data have emerged as to develop non-structural protein-based vaccines (Bailey et al., 2018; Lin et al., 1998) . In addition to non-structural protein-based vaccines, non-structural protein-specific antibodies would also be expected to be used for developing antiviral drugs that inhibit virus replication. Research reported that PRRSV nsp9-specific nanobodies that delivered into MARC-145 cells and PAMs can efficiently inhibited the replication of several PRRSV strains (Liu et al., 2015; Wang et al., 2019) . In this study, the results showed that expression level of cytokine IL-2, IL-4, IL-10, TNF-α, IFN-γ in splenocytes or sera from immunized mice increased, indicating that nsp10 can promote cellular immunity ( Fig. 5B-C) . Modified seroneutralization test indicated that nsp10 antibodies from immunized mouse sera may protect cells from PEDV infection (Fig.6 ). In addition, we aware of several limitations of this study, which all experiments involving the immunogenicity of PEDV nsp10 were carried out in mice. As pigs are the natural host of PEDV, in vivo studies on the protective immunity of PEDV nsp10 are certainly required in the future.

In conclusion, full-length nsp10 amplified from CV777 strain was expressed in E.coli, which protein yields were considerable high. Immunization challenge studies in mice, demonstrate that PEDV nsp10 induced robustly humoral and cellular immune responses. Furthermore, nsp10

antibodies from immunized mouse sera may have protective effect on cells from PEDV infection.

Despite these potential limitations, we believe that the nsp10 protein has potential for use in developing effective and safe anti-PEDV drugs for PED prevention.

This work was supported by 31860038 and 31960699 from the National Science Grant of China.

There were no potential conflicts (financial, professional or personal) that are relevant to the manuscript. 

Structure of

Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model

T cells and their function in the immune response to viruses

In vitro reconstitution of SARS-coronavirus mRNA cap methylation

RNA 3'-end mismatch excision by the severe acute respiratory syndrome coronavirus nonstructural protein nsp10/nsp14 exoribonuclease complex

Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus

Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6 suggests that nsp10 plays a critical role in polyprotein processing

Murine hepatitis virus replicase protein nsp10 is a critical regulator of viral RNA synthesis

Vaccines for the prevention against the threat of MERS-CoV

Genome organization of porcine epidemic diarrhoea virus

Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine

NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice

Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs

Short peptides derived from the interaction domain of SARS coronavirus nonstructural protein nsp10 can suppress the 2'-O-methyltransferase activity of nsp10/nsp16 epidemic diarrhea virus could provide piglets against homologous challenge

Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design

DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice

An intracellularly expressed Nsp9-specific nanobody in MARC-145 cells inhibits porcine reproductive and respiratory syndrome virus replication

Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses

S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen

PCR-Based Detection Methods for Single-Nucleotide Polymorphism or Mutation: Real-Time PCR and Its Substantial Contribution Toward Technological Refinement

The non-structural protein Nsp10 of mouse hepatitis virus binds zinc ions and nucleic acids

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus innate immunity to promote viral proliferation

The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing

Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines

Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10

SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets

Outbreak of porcine epidemic diarrhea in suckling piglets

Evidence of recombinant strains of porcine epidemic diarrhea virus

Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit

Identification of a virus-specific and conserved B-cell epitope on NS1 protein of Japanese encephalitis virus

Porcine epidemic diarrhea in China

A Nanobody Targeting Viral Nonstructural Protein 9 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication

Infection, genetic and virulence characteristics of porcine epidemic diarrhea virus in northwest China

Coronavirus nsp10/nsp16 Methyltransferase Can Be Targeted by nsp10-Derived